About SUBLOCADE

Why SUBLOCADE?

SUBLOCADE continuously releases medicine all month at sustained levels without real daily ups and downs.

SUBLOCADE is part of a complete treatment plan that should include counseling.

Find a buprenorphine treatment provider

The Substance Abuse and Mental Health Services Agency (SAMHSA) also provides treatment information. Visit the SAMHSA website to find a facility near you that can provide treatment based on patient-specific criteria. Download steps for using SAMHSA's 
Treatment Services Locator
.

For more information on how to find a facility, call INSUPPORT® at 1-844-467-7778.

SUBLOCADE and treatment success*

In a clinical study, SUBLOCADE patients were 14x* more likely to achieve treatment success.

*28% of people with SUBLOCADE plus counseling compared to 2% of people with placebo plus counseling.

In a 24-week study, treatment success was defined as opioid-free at least 80% of the weeks in treatment. Opioid-free means urine sample tested negative for illicit opioids plus no self-reported use of opioids. Weeks were not always consecutive.

Continuously releases buprenorphine all month

No real daily ups and downs.

Blocks the rewarding effects of opioids, which are the "pleasurable feelings" that can keep people using.

In a 12-week study of 39 non-treatment-seeking adults, SUBLOCADE blocked the rewarding effects of opioids.

Sustains the therapeutic level of buprenorphine in the blood throughout the month

SUBLOCADE is part of a complete treatment plan that should include counseling. The role of counseling is to help patients manage emotions and behaviors that can be linked to opioid addiction.

See How

Why counseling is part of treatment

Opioid addiction impacts a person’s behaviors. Counseling can help people deal with those behaviors and emotions often linked to addiction. It can also teach long-term coping skills for stress and help people start positive routines.

Treatment that combines medication and counseling has been shown to be more effective than using one of these methods alone. Talk to your treatment provider for help finding counseling.

Learn about the treatment approach that includes medication and counseling.

Curious about how SUBLOCADE works?

Find out how the unique extended-release delivery system gives you medicine all month.

Learn More

What’s the most important information to know about SUBLOCADE?

Because of the serious risk of potential harm or death from self-injecting SUBLOCADE into a vein (intravenously), it is only available through a restricted program called the SUBLOCADE REMS Program.

  • SUBLOCADE is not available in retail pharmacies.
  • Your SUBLOCADE injection will only be given to you by a certified healthcare provider.

SUBLOCADE contains an opioid medicine called buprenorphine that can cause serious and life-threatening breathing problems, especially if you take or use certain other medicines or drugs.

Talk to your healthcare provider about naloxone, a medicine available to patients for emergency treatment of an opioid overdose. If naloxone is given, you must call 911 or get emergency medical help right away to treat overdose or accidental use of an opioid.

SUBLOCADE may cause serious and life‐threatening breathing problems. Get emergency help right away if you:

  • feel faint
  • feel dizzy
  • are confused
  • feel sleepy or uncoordinated
  • have blurred vision
  • have slurred speech
  • are breathing slower than normal
  • cannot think well or clearly

Do not take certain medicines during treatment with SUBLOCADE. Taking other opioid medicines, benzodiazepines, alcohol, or other central nervous system depressants (including street drugs) while on SUBLOCADE can cause severe drowsiness, decreased awareness, breathing problems, coma, and death.

  • In an emergency, have family members tell emergency department staff that you are physically dependent on an opioid and are being treated with SUBLOCADE.
  • You may have detectable levels of SUBLOCADE in your body for a long period after stopping treatment with SUBLOCADE.

Death has been reported in those who are not opioid dependent who received buprenorphine sublingually.

Call your healthcare provider for medical advice about side effects. You may also report side effects to the FDA at FDA at 1-800-FDA-1088.

Want information?

Find out more about opioid addiction and treating it.

Get Updates